The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...
In a different type of signaling event, the scientists fused the binding proteins to a newly designed nanopore, a protein ...
The accurate determination of protein concentration is a foundational requirement in molecular biology, proteomics, and clinical diagnostics. Choosing the most appropriate protein quantification ...